Over the years, Farmacon Global’s success has been a testament to our steadfast commitment to excellence, specifically in navigating the intricacies of clinical research. Our focus areas include Immunology, Rare and Infectious Diseases, Cancer, and the emerging market of Latin America.

Past & Current Sponsors

Farmacon Global’s Recent Successes in Rare Diseases:

Farmacon Global’s Recent Successes in COVID-19 and Vaccines:

Sara Tylosky, MBA

Sara Tylosky, MBA, CEO at Farmacon Global, brings over 20 years of experience leading teams in both large and small pharmaceutical and biotech environments. She has led Farmacon Global, a strategic CRO of medical consultants, in accelerating clinical trials, increasing diversity, supporting enrollment, and paving the way to market access in emerging markets.

Known for her high cultural intelligence and problem-solving skills, Sara and her team specialize in Rare Diseases, Immunology, Infectious Diseases, Cancer, and Vaccines. Fluent in Spanish and having lived on four continents, she has a special focus on Latin America while actively expanding into other key markets globally. Sara’s direction plays a pivotal role in steering Farmacon Global toward healthcare innovation and global market leadership.